FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2088111193> ?p ?o ?g. }

• W2088111193 endingPage "71" @default.
• W2088111193 startingPage "67" @default.
• W2088111193 abstract "OBJECTIVE--To investigate the clinical presentation and current management strategies of pericardial effusion in patients with malignancy. DESIGN--Retrospective single centre, consecutive observational study. SETTING--University hospital. PATIENTS--93 consecutive patients with a past or present diagnosis of cancer and a pericardial effusion, including 50 with a pericardial effusion > 1 cm. RESULTS--Of the 50 patients with pericardial effusions > 1 cm, most had stage 4 cancer (64%), were symptomatic at the time of presentation (74%), and had right atrial collapse (74%). Twenty patients were treated conservatively (without pericardiocentesis) and were less symptomatic (55% v 87%, P = 0.012), had smaller pericardial effusions (1.5 (0.4) v 1.8 (0.5), P = 0.02), and less frequent clinical (10% v 40%, P = 0.02) and echocardiographic evidence of tamponade (40% v 97%, P < 0.001) than the 30 patients treated invasively with initial pericardiocentesis (n = 29) or pericardial window placement (n = 1). Pericardial tamponade requiring repeat pericardiocentesis occurred in 18 (62%) of 29 patients after a median of 7 days. In contrast, only four (20%) of 20 patients in the conservative group progressed to frank clinical tamponade and required pericardiocentesis (P = 0.005 v invasive group). The overall median survival was 2 months with a survival rate at 48 months of 26%. Survival, duration of hospital stay, and hospital charges were similar with both strategies. By multivariable analysis, the absence of symptoms was the only independent predictor of long-term survival (relative hazards ratio = 3.2, P = 0.05). Survival was similar in the 43 patients with cancer and pericardial effusions of < or = 1 cm. CONCLUSION--Asymptomatic patients with cancer and pericardial effusion can be managed conservatively with close follow up. In patients with symptoms or clinical cardiac tamponade, pericardiocentesis provides relief of symptoms but does not improve survival and has a high recurrence rate. Surgical pericardial windows or possibly percutaneous balloon pericardiotomy should be used for recurrences and should be considered for initial treatment." @default.
• W2088111193 created "2016-06-24" @default.
• W2088111193 creator A5028677517 @default.
• W2088111193 creator A5050137847 @default.
• W2088111193 creator A5060933839 @default.
• W2088111193 creator A5064437329 @default.
• W2088111193 creator A5082506991 @default.
• W2088111193 creator A5085665354 @default.
• W2088111193 date "1996-01-01" @default.
• W2088111193 modified "2023-10-05" @default.
• W2088111193 title "Pericardial effusion in patients with cancer: outcome with contemporary management strategies." @default.
• W2088111193 cites W1601730771 @default.
• W2088111193 cites W177439075 @default.
• W2088111193 cites W1964697154 @default.
• W2088111193 cites W1966112821 @default.
• W2088111193 cites W1971164858 @default.
• W2088111193 cites W1974087659 @default.
• W2088111193 cites W1984628336 @default.
• W2088111193 cites W1984816090 @default.
• W2088111193 cites W1993270370 @default.
• W2088111193 cites W1995556138 @default.
• W2088111193 cites W2000534195 @default.
• W2088111193 cites W2001775792 @default.
• W2088111193 cites W2002520194 @default.
• W2088111193 cites W2009277139 @default.
• W2088111193 cites W2012072754 @default.
• W2088111193 cites W2023146055 @default.
• W2088111193 cites W2027203138 @default.
• W2088111193 cites W2033512317 @default.
• W2088111193 cites W2035253052 @default.
• W2088111193 cites W2044260483 @default.
• W2088111193 cites W2045671863 @default.
• W2088111193 cites W2046657022 @default.
• W2088111193 cites W2048054851 @default.
• W2088111193 cites W2057960867 @default.
• W2088111193 cites W2079542042 @default.
• W2088111193 cites W2109530085 @default.
• W2088111193 cites W2163359621 @default.
• W2088111193 cites W2412125167 @default.
• W2088111193 cites W4214513261 @default.
• W2088111193 cites W4244087239 @default.
• W2088111193 cites W4321001047 @default.
• W2088111193 doi "https://doi.org/10.1136/hrt.75.1.67" @default.
• W2088111193 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/484225" @default.
• W2088111193 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8624876" @default.
• W2088111193 hasPublicationYear "1996" @default.
• W2088111193 type Work @default.
• W2088111193 sameAs 2088111193 @default.
• W2088111193 citedByCount "101" @default.
• W2088111193 countsByYear W20881111932012 @default.
• W2088111193 countsByYear W20881111932013 @default.
• W2088111193 countsByYear W20881111932014 @default.
• W2088111193 countsByYear W20881111932015 @default.
• W2088111193 countsByYear W20881111932016 @default.
• W2088111193 countsByYear W20881111932017 @default.
• W2088111193 countsByYear W20881111932018 @default.
• W2088111193 countsByYear W20881111932020 @default.
• W2088111193 countsByYear W20881111932022 @default.
• W2088111193 countsByYear W20881111932023 @default.
• W2088111193 crossrefType "journal-article" @default.
• W2088111193 hasAuthorship W2088111193A5028677517 @default.
• W2088111193 hasAuthorship W2088111193A5050137847 @default.
• W2088111193 hasAuthorship W2088111193A5060933839 @default.
• W2088111193 hasAuthorship W2088111193A5064437329 @default.
• W2088111193 hasAuthorship W2088111193A5082506991 @default.
• W2088111193 hasAuthorship W2088111193A5085665354 @default.
• W2088111193 hasBestOaLocation W20881111931 @default.
• W2088111193 hasConcept C126322002 @default.
• W2088111193 hasConcept C141071460 @default.
• W2088111193 hasConcept C163430725 @default.
• W2088111193 hasConcept C167135981 @default.
• W2088111193 hasConcept C2777573719 @default.
• W2088111193 hasConcept C2778005868 @default.
• W2088111193 hasConcept C2778607678 @default.
• W2088111193 hasConcept C2779074627 @default.
• W2088111193 hasConcept C2779399171 @default.
• W2088111193 hasConcept C2781175549 @default.
• W2088111193 hasConcept C71924100 @default.
• W2088111193 hasConceptScore W2088111193C126322002 @default.
• W2088111193 hasConceptScore W2088111193C141071460 @default.
• W2088111193 hasConceptScore W2088111193C163430725 @default.
• W2088111193 hasConceptScore W2088111193C167135981 @default.
• W2088111193 hasConceptScore W2088111193C2777573719 @default.
• W2088111193 hasConceptScore W2088111193C2778005868 @default.
• W2088111193 hasConceptScore W2088111193C2778607678 @default.
• W2088111193 hasConceptScore W2088111193C2779074627 @default.
• W2088111193 hasConceptScore W2088111193C2779399171 @default.
• W2088111193 hasConceptScore W2088111193C2781175549 @default.
• W2088111193 hasConceptScore W2088111193C71924100 @default.
• W2088111193 hasIssue "1" @default.
• W2088111193 hasLocation W20881111931 @default.
• W2088111193 hasLocation W20881111932 @default.
• W2088111193 hasLocation W20881111933 @default.
• W2088111193 hasLocation W20881111934 @default.
• W2088111193 hasOpenAccess W2088111193 @default.
• W2088111193 hasPrimaryLocation W20881111931 @default.
• W2088111193 hasRelatedWork W131207663 @default.
• W2088111193 hasRelatedWork W1968312403 @default.

• next